The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Glucose Monitoring Market Research Report 2024
Synopsis
One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.
The global Blood Glucose Monitoring market was valued at US$ 7877 million in 2023 and is anticipated to reach US$ 10610 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Glucose Monitoring.
Report Scope
The Blood Glucose Monitoring market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Glucose Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Segment by Type
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Segment by Application
Hospitals Diagnostic Centers
Home Settings
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Glucose Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.
The global Blood Glucose Monitoring market was valued at US$ 7877 million in 2023 and is anticipated to reach US$ 10610 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Glucose Monitoring.
Report Scope
The Blood Glucose Monitoring market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Glucose Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Segment by Type
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Segment by Application
Hospitals Diagnostic Centers
Home Settings
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Glucose Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Glucose Monitoring Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single Point Blood Glucose Meters
1.2.3 Continuous Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Blood Glucose Monitoring Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals Diagnostic Centers
1.3.3 Home Settings
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Glucose Monitoring Market Perspective (2019-2030)
2.2 Blood Glucose Monitoring Growth Trends by Region
2.2.1 Global Blood Glucose Monitoring Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Glucose Monitoring Historic Market Size by Region (2019-2024)
2.2.3 Blood Glucose Monitoring Forecasted Market Size by Region (2025-2030)
2.3 Blood Glucose Monitoring Market Dynamics
2.3.1 Blood Glucose Monitoring Industry Trends
2.3.2 Blood Glucose Monitoring Market Drivers
2.3.3 Blood Glucose Monitoring Market Challenges
2.3.4 Blood Glucose Monitoring Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Glucose Monitoring Players by Revenue
3.1.1 Global Top Blood Glucose Monitoring Players by Revenue (2019-2024)
3.1.2 Global Blood Glucose Monitoring Revenue Market Share by Players (2019-2024)
3.2 Global Blood Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Glucose Monitoring Revenue
3.4 Global Blood Glucose Monitoring Market Concentration Ratio
3.4.1 Global Blood Glucose Monitoring Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Glucose Monitoring Revenue in 2023
3.5 Blood Glucose Monitoring Key Players Head office and Area Served
3.6 Key Players Blood Glucose Monitoring Product Solution and Service
3.7 Date of Enter into Blood Glucose Monitoring Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Glucose Monitoring Breakdown Data by Type
4.1 Global Blood Glucose Monitoring Historic Market Size by Type (2019-2024)
4.2 Global Blood Glucose Monitoring Forecasted Market Size by Type (2025-2030)
5 Blood Glucose Monitoring Breakdown Data by Application
5.1 Global Blood Glucose Monitoring Historic Market Size by Application (2019-2024)
5.2 Global Blood Glucose Monitoring Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Glucose Monitoring Market Size (2019-2030)
6.2 North America Blood Glucose Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Glucose Monitoring Market Size by Country (2019-2024)
6.4 North America Blood Glucose Monitoring Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Glucose Monitoring Market Size (2019-2030)
7.2 Europe Blood Glucose Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Glucose Monitoring Market Size by Country (2019-2024)
7.4 Europe Blood Glucose Monitoring Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Glucose Monitoring Market Size (2019-2030)
8.2 Asia-Pacific Blood Glucose Monitoring Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Glucose Monitoring Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Glucose Monitoring Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Glucose Monitoring Market Size (2019-2030)
9.2 Latin America Blood Glucose Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Glucose Monitoring Market Size by Country (2019-2024)
9.4 Latin America Blood Glucose Monitoring Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Glucose Monitoring Market Size (2019-2030)
10.2 Middle East & Africa Blood Glucose Monitoring Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Glucose Monitoring Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Glucose Monitoring Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Blood Glucose Monitoring Introduction
11.1.4 Abbott Laboratories Revenue in Blood Glucose Monitoring Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 ARKRAY, Inc.
11.2.1 ARKRAY, Inc. Company Detail
11.2.2 ARKRAY, Inc. Business Overview
11.2.3 ARKRAY, Inc. Blood Glucose Monitoring Introduction
11.2.4 ARKRAY, Inc. Revenue in Blood Glucose Monitoring Business (2019-2024)
11.2.5 ARKRAY, Inc. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Detail
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Blood Glucose Monitoring Introduction
11.3.4 Bayer AG Revenue in Blood Glucose Monitoring Business (2019-2024)
11.3.5 Bayer AG Recent Development
11.4 Dexcom, Inc.
11.4.1 Dexcom, Inc. Company Detail
11.4.2 Dexcom, Inc. Business Overview
11.4.3 Dexcom, Inc. Blood Glucose Monitoring Introduction
11.4.4 Dexcom, Inc. Revenue in Blood Glucose Monitoring Business (2019-2024)
11.4.5 Dexcom, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Blood Glucose Monitoring Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Blood Glucose Monitoring Introduction
11.6.4 Johnson & Johnson Revenue in Blood Glucose Monitoring Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Medtronic plc
11.7.1 Medtronic plc Company Detail
11.7.2 Medtronic plc Business Overview
11.7.3 Medtronic plc Blood Glucose Monitoring Introduction
11.7.4 Medtronic plc Revenue in Blood Glucose Monitoring Business (2019-2024)
11.7.5 Medtronic plc Recent Development
11.8 Nipro Diagnostics, Inc.
11.8.1 Nipro Diagnostics, Inc. Company Detail
11.8.2 Nipro Diagnostics, Inc. Business Overview
11.8.3 Nipro Diagnostics, Inc. Blood Glucose Monitoring Introduction
11.8.4 Nipro Diagnostics, Inc. Revenue in Blood Glucose Monitoring Business (2019-2024)
11.8.5 Nipro Diagnostics, Inc. Recent Development
11.9 Terumo Medical Corporation
11.9.1 Terumo Medical Corporation Company Detail
11.9.2 Terumo Medical Corporation Business Overview
11.9.3 Terumo Medical Corporation Blood Glucose Monitoring Introduction
11.9.4 Terumo Medical Corporation Revenue in Blood Glucose Monitoring Business (2019-2024)
11.9.5 Terumo Medical Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
